UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | E | F | G | H | J | L | N | P | V
Number of items: 22.

A

ALLEN, DG; BAAK, J; BELPOMME, D; BEREK, JS; BERTELSEN, K; HUININK, WWT; VANDERBURG, MEL; (1993) ADVANCED EPITHELIAL OVARIAN-CANCER - 1993 CONSENSUS STATEMENTS. ANN ONCOL , 4 83 - 88.

B

BEGENT, RHJ; CHESTER, KA; CONNORS, T; CROWTHER, D; FOX, B; GRIFFITHS, E; HINCE, TA; (1993) CANCER-RESEARCH CAMPAIGN OPERATION MANUAL FOR CONTROL RECOMMENDATIONS FOR PRODUCTS DERIVED FROM RECOMBINANT-DNA TECHNOLOGY PREPARED FOR INVESTIGATIONAL ADMINISTRATION TO PATIENTS WITH CANCER IN PHASE-I TRIALS. EUR J CANCER , 29A (13) 1907 - 1910.

Beyaert, R; Vanhaesebroeck, B; Heyninck, K; Boone, E; De Valck, D; Schulze-Osthoff, K; Haegeman, G; (1993) Sensitization of tumor cells to tumor necrosis factor action by the protein kinase inhibitor staurosporine. Cancer Res , 53 (11) pp. 2623-2630.

C

CALVERT, AH; LIND, MJ; MILLWARD, MM; CANTWELL, BMJ; GUMBRELL, L; PROCTOR, M; SIMMONS, D; (1993) LONG-TERM ORAL ETOPOSIDE IN METASTATIC BREAST-CANCER - CLINICAL AND PHARMACOKINETIC RESULTS. CANCER TREAT REV , 19 27 - 33.

CALVERT, H; JUDSON, I; VANDERVIJGH, WJF; (1993) PLATINUM COMPLEXES IN CANCER MEDICINE - PHARMACOKINETICS AND PHARMACODYNAMICS IN RELATION TO TOXICITY AND THERAPEUTIC ACTIVITY. CANCER SURV , 17 189 - 217.

CAYEUX, SJ; BEVERLEY, PCL; SCHULZ, R; DORKEN, B; (1993) ELEVATED PLASMA PROSTAGLANDIN E(2) LEVELS FOUND IN 14 PATIENTS UNDERGOING AUTOLOGOUS BONE-MARROW OR STEM-CELL TRANSPLANTATION. BONE MARROW TRANSPL , 12 (6) 603 - 608.

CHIANELLI, M; SIGNORE, A; HICKS, R; TESTI, R; NEGRI, M; BEVERLEY, PCL; (1993) A SIMPLE METHOD FOR THE EVALUATION OF RECEPTOR-BINDING CAPACITY OF MODIFIED CYTOKINES. J IMMUNOL METHODS , 166 (2) 177 - 182.

E

Evans, TR; Stein, RC; Pepper, JR; Gazet, JC; Ford, HT; Coombes, RC; (1993) A randomised prospective trial of surgical against medical tetracycline pleurodesis in the management of malignant pleural effusions secondary to breast cancer. Eur J Cancer , 29A (3) pp. 316-319.

F

FISHER, TC; MILNER, AE; GREGORY, CD; JACKMAN, AL; AHERNE, GW; HARTLEY, JA; DIVE, C; (1993) BCL-2 MODULATION OF APOPTOSIS INDUCED BY ANTICANCER DRUGS - RESISTANCE TO THYMIDYLATE STRESS IS INDEPENDENT OF CLASSICAL RESISTANCE PATHWAYS. CANCER RES , 53 (14) 3321 - 3326.

FOSTER, BJ; NEWELL, DR; CARMICHAEL, J; HARRIS, AL; GUMBRELL, LA; JONES, M; GOODARD, PM; (1993) PRECLINICAL, PHASE-I AND PHARMACOKINETIC STUDIES WITH THE DIMETHYL PHENYLTRIAZENE-CB10-277. BRIT J CANCER , 67 (2) 362 - 368.

FOSTER, BJ; NEWELL, DR; GUMBRELL, LA; JENNS, KE; CALVERT, AH; (1993) PHASE-I TRIAL WITH PHARMACOKINETICS OF CB10-277 GIVEN BY 24 HOURS CONTINUOUS INFUSION. BRIT J CANCER , 67 (2) 369 - 373.

G

Grooten, J; Goossens, V; Vanhaesebroeck, B; Fiers, W; (1993) Cell membrane permeabilization and cellular collapse, followed by loss of dehydrogenase activity: early events in tumour necrosis factor-induced cytotoxicity. Cytokine , 5 (6) pp. 546-555.

H

HARTLEY, JA; SOUHAMI, RL; BERARDINI, MD; (1993) ELECTROPHORETIC AND CHROMATOGRAPHIC-SEPARATION METHODS USED TO REVEAL INTERSTRAND CROSS-LINKING OF NUCLEIC-ACIDS. J CHROMATOGR-BIOMED , 618 (1-2) 277 - 288.

HARTLEY, JM; NICHOLSON, PW; ALLEN, R; LAMOND, P; HARLAND, SJ; SOUHAMI, RL; (1993) PHARMACOKINETICS OF 10-ETHYL-10-DEAZA-AMINOPTERIN, EDATREXATE, GIVEN WEEKLY FOR NON-SMALL-CELL LUNG-CANCER. CANCER CHEMOTH PHARM , 31 (4) 328 - 332.

Hochhauser, D; Harris, AL; (1993) The role of topoisomerase II alpha and beta in drug resistance. Cancer Treat Rev , 19 (2) pp. 181-194.

J

JACKMAN, AL; BISSET, GMF; JODRELL, DI; GIBSON, W; KIMBELL, R; BAVETSIAS, V; CALVERT, AH; (1993) GAMMA-LINKED DIPEPTIDE ANALOGS OF 2-DESAMINO-2-METHYL-N-10-PROPARGYL-5,8-DIDEAZAFOLATE AS ANTITUMOR AGENTS. CHEMISTRY AND BIOLOGY OF PTERIDINES AND FOLATES , 338 579 - 584.

L

LEE, M; RHODES, AL; WYATT, MD; DINCALCI, M; FORROW, S; HARTLEY, JA; (1993) INVITRO CYTOTOXICITY OF GC SEQUENCE DIRECTED ALKYLATING-AGENTS RELATED TO DISTAMYCIN. J MED CHEM , 36 (7) 863 - 870.

N

Newell, DR; Pearson, AD; Balmanno, K; Price, L; Wyllie, RA; Keir, M; Calvert, AH; (1993) Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group. J Clin Oncol , 11 (12) pp. 2314-2323. 10.1200/jco.1993.11.12.2314.

P

PEDLEY, RB; BODEN, JA; BODEN, R; DALE, R; BEGENT, RHJ; (1993) COMPARATIVE RADIOIMMUNOTHERAPY USING INTACT OF F(AB')2 FRAGMENTS OF I-131 ANTI-CEA ANTIBODY IN A COLONIC XENOGRAFT MODEL. BRIT J CANCER , 68 (1) 69 - 73.

PUVVADA, MS; HARTLEY, JA; JENKINS, TC; THURSTON, DE; (1993) A quantitative assay to measure the relative dna-binding affinity of pyrrolo[2,1-c][1,4]benzodiazepine (pbd) antitumor antibiotics based on the inhibition of restriction-endonuclease bamhi. Nucleic Acids Research , 21 (16) 3671 - 3675. 10.1093/nar/21.16.3671. Green open access
file

Perren, TJ; Wiltshaw, E; Harper, P; Slevin, M; Stein, R; Tan, S; Gore, M; (1993) A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma. The London Gynaecologic Oncology Group. Br J Cancer , 68 (6) pp. 1190-1194.

V

Vanhaesebroeck, B; Reed, JC; De Valck, D; Grooten, J; Miyashita, T; Tanaka, S; Beyaert, R; (1993) Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity. Oncogene , 8 (4) pp. 1075-1081.

This list was generated on Sun Nov 27 03:09:44 2016 GMT.